Doribax News
Most Popular Doribax Story
FDA wants more information on Doribax
Johnson & Johnson is having a hard time making its case to the FDA for using Doribax as a therapy for... Read more...
Latest Headlines
- August 21, 2008
Paid Research Reports
- RNA therapy: the next big thing after monoclonal antibodies?
- Biotech M&A Strategies: Deal assessments, trends and future prospects
- The Dermatology Market Outlook to 2013: Competitive landscape, pipeline analysis and growth opportunities
- Pipeline Insight: Cancer Overview - Breast, Gynecological, Genitourinary - Diverse drugs approaching the market for many tumor t
- Sales Force Effectiveness


